Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 13/20 | 0.61 |
| ▸ | CNR2 | P34972 | 10/20 | 0.61 |
| ▸ | HTR2A | P28223 | 3/20 | 0.53 |
| ▸ | HTR2C | P28335 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL738485 | 0.87 | CNR1 (0.68) | CNR1CNR2HTR2AHTR2C | |
| SCHEMBL6102985 | 0.83 | CNR1 (0.67) | CNR1CNR2 | |
| SCHEMBL3683934 | 0.83 | CNR1 (0.89) | CNR1CNR2 | |
| SCHEMBL6106568 | 0.82 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL4914879 | 0.81 | CNR1 (0.61) | CNR1CNR2 | |
| SCHEMBL24238305 | 0.80 | CNR1 (0.60) | CNR1CNR2 | |
| SCHEMBL30961580 | 0.80 | CNR1 (0.60) | CNR1CNR2 | |
| SCHEMBL4923037 | 0.79 | CNR1 (0.57) | CNR1CNR2 | |
| SCHEMBL3680322 | 0.79 | CNR1 (0.71) | CNR1CNR2 | |
| SCHEMBL4065973 | 0.78 | CNR1 (0.69) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2026798-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS | Solvay Pharmaceuticals GmbH (DE) | 2009-02-25 | — | — | EP | disclosed |
| WO-2007125048-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2007-11-08 | — | — | WO | disclosed |